BioSpace News Archive

The company indicates that the overall data from the vixotrigine program will help them determine dose levels for future Phase III trials.

According to Bloomberg, the Work Trend Index showed that 41% of the survey’s 30,000 respondents planned on leaving their current job.

Moderna will leverage AbCellera’s AI-powered technology to search and analyze natural immune responses in the hopes of identifying antibodies for up to six targets.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Force Therapeutics, the leading patient engagement platform and research network, exceeded 110 clinical research publications today.

Asymchem (stock code: 002821.SZ) today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany.

Exegenesis Bio is pleased to announce the appointment of Mahen Gundecha as Chief Business Officer.

Leading biotech beauty brand, Codex Beauty Labs , has been granted two U.S. patents related to its newest skincare line, Antü®.

Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases.